vs
Side-by-side financial comparison of Golden Matrix Group, Inc. (GMGI) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $49.6M, roughly 1.4× Golden Matrix Group, Inc.). Viridian Therapeutics, Inc.\DE runs the higher net margin — -49.0% vs -179.0%, a 129.9% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -15.8%). Golden Matrix Group, Inc. produced more free cash flow last quarter ($6.4M vs $-84.7M).
Golden Matrix Group Inc. is a global gaming tech firm that develops and licenses proprietary online gaming platforms, social casino products and interactive solutions. It serves B2B gaming operator clients across North America, Europe and Asia-Pacific, plus runs direct-to-consumer casual gaming properties.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
GMGI vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $49.6M | $70.6M |
| Net Profit | $-88.7M | $-34.6M |
| Gross Margin | 57.5% | — |
| Operating Margin | -188.3% | -56.7% |
| Net Margin | -179.0% | -49.0% |
| Revenue YoY | -15.8% | 81958.1% |
| Net Profit YoY | -4880.1% | 54.9% |
| EPS (diluted) | $-7.73 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $49.6M | — | ||
| Q3 25 | $47.3M | $70.6M | ||
| Q2 25 | $43.2M | — | ||
| Q1 25 | $42.7M | — | ||
| Q4 24 | $58.9M | — | ||
| Q3 24 | $41.0M | — | ||
| Q2 24 | $39.4M | — | ||
| Q1 24 | $11.8M | — |
| Q4 25 | $-88.7M | — | ||
| Q3 25 | $566.0K | $-34.6M | ||
| Q2 25 | $-3.6M | — | ||
| Q1 25 | $-231.6K | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $-3.4M | — | ||
| Q2 24 | $64.9K | — | ||
| Q1 24 | $74.5K | — |
| Q4 25 | 57.5% | — | ||
| Q3 25 | 55.8% | — | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.6% | — | ||
| Q4 24 | 69.8% | — | ||
| Q3 24 | 54.7% | — | ||
| Q2 24 | 55.0% | — | ||
| Q1 24 | 28.5% | — |
| Q4 25 | -188.3% | — | ||
| Q3 25 | -0.8% | -56.7% | ||
| Q2 25 | -5.3% | — | ||
| Q1 25 | -0.2% | — | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | -2.4% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 2.4% | — |
| Q4 25 | -179.0% | — | ||
| Q3 25 | 1.2% | -49.0% | ||
| Q2 25 | -8.3% | — | ||
| Q1 25 | -0.5% | — | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | -8.3% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | $-7.73 | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $-0.03 | — | ||
| Q1 25 | $0.00 | — | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | $-0.03 | — | ||
| Q2 24 | $0.00 | — | ||
| Q1 24 | $0.00 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $46.5M | $503.0M |
| Total Assets | $118.1M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $490.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $46.5M | — | ||
| Q3 25 | $123.5M | $503.0M | ||
| Q2 25 | $121.3M | — | ||
| Q1 25 | $108.5M | — | ||
| Q4 24 | $105.1M | — | ||
| Q3 24 | $94.3M | — | ||
| Q2 24 | $90.4M | — | ||
| Q1 24 | $32.1M | — |
| Q4 25 | $118.1M | — | ||
| Q3 25 | $209.8M | $577.1M | ||
| Q2 25 | $210.3M | — | ||
| Q1 25 | $214.0M | — | ||
| Q4 24 | $213.7M | — | ||
| Q3 24 | $213.5M | — | ||
| Q2 24 | $191.5M | — | ||
| Q1 24 | $37.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $-84.6M |
| Free Cash FlowOCF − Capex | $6.4M | $-84.7M |
| FCF MarginFCF / Revenue | 13.0% | -120.1% |
| Capex IntensityCapex / Revenue | 3.6% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $19.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | — | ||
| Q3 25 | $7.0M | $-84.6M | ||
| Q2 25 | $2.4M | — | ||
| Q1 25 | $7.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $4.8M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $8.2K | — |
| Q4 25 | $6.4M | — | ||
| Q3 25 | $6.2M | $-84.7M | ||
| Q2 25 | $-89.4K | — | ||
| Q1 25 | $6.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $6.7K | — |
| Q4 25 | 13.0% | — | ||
| Q3 25 | 13.1% | -120.1% | ||
| Q2 25 | -0.2% | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | 3.6% | — | ||
| Q3 25 | 1.8% | 0.2% | ||
| Q2 25 | 5.7% | — | ||
| Q1 25 | 2.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | 12.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.11× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GMGI
| R Kings And CFAC | $43.8M | 88% |
| Other | $5.8M | 12% |
VRDN
Segment breakdown not available.
